DRTS vs ADRX
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
DRTS · Alpha Tau Medical$13.72 ▲ 3.16%
ADRX · Adarx Pharmaceuticals$13.23 ▼ 0.45%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- DRTS -5.6%
- ADRX -31.6%
Head to head
| Metric | DRTS | ADRX |
|---|---|---|
| Price | $13.72 | $13.23 |
| Change today | ▲ 3.16% | ▼ 0.45% |
| Market cap | $1.27B | $1.35B |
| Return, 3 months | +0.9% | – |
| Return, year to date | +177.2% | – |
| Return, 1 year | +255.4% | – |
| P/E (TTM) | -13.2 | -15.4 |
| P/B | 28.8 | -5.4 |
| P/E percentile vs own 5y | 32nd | 87th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +258.7% |
| Net profit growth (YoY) | -353.0% | -42.4% |
| Gross margin | – | – |
| Operating margin | – | -1,735.0% |
| Net margin | – | -1,434.1% |
| Return on equity | -141.7% | – |
| Analyst target vs. price | +67.6% | +164.6% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 51 | 22 |
| 30-day volatility | 49.7% | 60.6% |
| Max drawdown, 1 year | -23.9% | -35.9% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ADRX is the largest of the group by market value.
- ADRX carries the lowest trailing P/E.
- DRTS has been the calmest stock over the last 30 days.